Complicaciones de la quimioembolización transarterial (QETA) en el tratamiento de los tumores hepáticos-Reference-Cited by-同舟云学术

Complicaciones de la quimioembolización transarterial (QETA) en el tratamiento de los tumores hepáticos

Published:2018-11 Issue:9 Volume:96 Page:560-567
ISSN:0009-739X
Container-title:Cirugía Española
language:es
Short-container-title:Cirugía Española

Author:

Marcacuzco Quinto Alberto,Nutu Oana-Anisa,San Román Manso Ricardo,Justo Alonso Iago,Calvo Pulido Jorge,Manrique Municio Alejandro,García-Sesma Álvaro,Loinaz Segurola Carmelo,Martínez Caballero Javier,Jiménez Romero Luis Carlos

Publisher

Elsevier BV

Subject

Surgery

Reference35 articles.

1. Hepatocellular carcinoma: Current management and future trends;Carr;Gastroenterology,2004

2. Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481);Kemeny;J Clin Oncol,2006

3. Embolization and chemoembolization therapy for neuroendocrine tumors;Venook;Curr Opin Oncol,1999

4. Surgical and locoregional therapy of HCC: TACE;Tsurusaki;Liver Cancer,2015

5. Correlation between angiographically assessed vascularity and blood flow in hepatic metastases in patients with colorectal carcinoma;Yamaguchi;Cancer,2000

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictors and risk factors of bile duct injury after transcatheter arterial chemoembolization for hepatocellular carcinoma;BMC Cancer;2024-09-02

2. Comprehensive review of clinical presentation, diagnosis, management, and prognosis of ruptured hepatocellular carcinoma;Journal of Gastrointestinal Surgery;2024-08

3. Examining the Efficacy and Safety of Combined Locoregional Therapy and Immunotherapy in Treating Hepatocellular Carcinoma;Biomedicines;2024-06-27

4. A Retrospective Cohort Analysis of Transarterial Chemoembolization for Hepatocellular Cancer at a Tertiary Center in Switzerland;Journal of Clinical Medicine;2024-06-02

5. Prognosis of transarterial chemoembolization-sorafenib compared to transarterial chemoembolization-alone in hepatocellular carcinoma stage C: a systematic review;Journal of the Egyptian National Cancer Institute;2024-05-27